دورية أكاديمية
Efficacy and safety of geptanolimab (GB226) for relapsed/refractory primary mediastinal large B-cell lymphoma: an open-label phase II study (Gxplore-003)
| العنوان: | Efficacy and safety of geptanolimab (GB226) for relapsed/refractory primary mediastinal large B-cell lymphoma: an open-label phase II study (Gxplore-003) |
|---|---|
| المؤلفون: | Shi, YuankaiAff1, IDs00262023034677_cor1, Cui, Jie, Zhou, Hui, Zhang, Xiaohong, Zou, Liqun, Cao, Junning, Gao, Yuhuan, Jin, Chuan, Li, Xiaoling, Liu, Hui, Peng, Zhigang, Xie, Liping, Zhang, Huilai, Zhang, Weihua, Zhang, Hongyu, Zhong, Liye, Zhou, Fang, Guo, Genny, He, Wenduo |
| المصدر: | Cancer Immunology, Immunotherapy. 72(9):2991-3002 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 03407004 14320851 |
|---|---|
| DOI: | 10.1007/s00262-023-03467-7 |